CITED2 and diabetes mellitus: In summary, we found that stem cell proliferation activity and angiogenesis of hADSCs under diabetes-associated glucolipotoxic conditions were increased in part by modulating the expression of miR-1248 via restraining the expression of CITED2, an inhibitor of HIF-1α.